| 6225 |
BCG Vaccine specifications |
12/10/2024 |
TB prevention including airborne infection control |
| 6179 |
Reporting of AEFIs - serious/severe AEFIs |
12/10/2024 |
TB prevention including airborne infection control |
| 6181 |
Strengthening AEFI surveillance for aBCG Vaccination |
12/10/2024 |
TB prevention including airborne infection control |
| 6175 |
Surveillance of AEFI following aBCG Vaccination |
12/10/2024 |
|
| 6189 |
BCG vaccine and AEFIs |
12/10/2024 |
TB prevention including airborne infection control |
| 6494 |
Adult BCG Vaccine Implementation Study- Human Resource Cost |
12/10/2024 |
TB prevention including airborne infection control |
| 6503 |
Communication Strategy for Adult BCG Vaccination |
12/10/2024 |
TB prevention including airborne infection control |
| 6518 |
Adult BCG Vaccine Implementation Study- Roles and responsibilities of stakeholders at National level |
12/10/2024 |
TB prevention including airborne infection control |
| 6335 |
Adult BCG vaccination-Study methodology and objectives |
12/10/2024 |
|
| 6776 |
Financial Norms for aBCG Vaccination |
12/10/2024 |
|
| 34 |
Adult BCG Vaccination |
12/10/2024 |
TB prevention including airborne infection control |
| 6155 |
Roles and responsibilities of stakeholders involved in aBCG Vaccine implementation study |
12/10/2024 |
|
| 6352 |
Micro-planning for aBCG vaccination |
12/10/2024 |
TB Vaccines |
| 6325 |
Orientation to Adult BCG (aBCG) Vaccination Study Protocol |
12/10/2024 |
TB Vaccines |
| 1982 |
TB deaths |
14/10/2024 |
Surveillance, SM&E and Epidemiology |
| 6793 |
Social Autopsy for TB deaths |
14/10/2024 |
|
| 4476 |
Differentiated TB care |
15/10/2024 |
Training and HR Development |
| 6795 |
Differentiated TB Care for other special cases |
15/10/2024 |
|
| 6755 |
Need for Differentiated TB Care |
16/10/2024 |
|
| 201 |
Onsite Evaluation [OSE] |
17/10/2024 |
Laboratory services and management |
| 204 |
RBRC Process |
18/10/2024 |
Laboratory services and management |
| 206 |
RBRC Process at DTC |
18/10/2024 |
Laboratory services and management |
| 87 |
Directly Observed Treatment Strategy [DOTS] |
18/10/2024 |
Training and HR Development |
| 51 |
Active Case Finding [ACF] |
18/10/2024 |
TB prevention including airborne infection control |
| 53 |
Intensified Case Finding [ICF] |
18/10/2024 |
Training and HR Development |
| 575 |
Direct Benefit Transfer [DBT] under NTEP |
18/10/2024 |
Ni-kshay, Information Systems and DBT |
| 593 |
Drug-Resistant Tuberculosis [DR-TB] |
18/10/2024 |
Training and HR Development |
| 592 |
Drug-Sensitive Tuberculosis [DS-TB] |
18/10/2024 |
Training and HR Development |
| 607 |
Management of Adverse Drug Reactions [ADRs] of TB Treatment |
18/10/2024 |
DR-TB and PMDT |
| 625 |
ADRs to First Line Treatment |
18/10/2024 |
DR-TB and PMDT |
